Across glucose ranges below 180 mg/dL, GLUCOSE consistently recommends lower average insulin doses than clinicians, reflecting a guideline-aligned strategy that prioritizes maintaining glucose between 140 and 180 mg/dL while reducing the risk for hypoglycemia. This evidence concerns the gene INS and Hypoglycemia.